Company

Remepy Health Ltd.

Remepy develops hybrid treatments combining pharmaceuticals with tailored digital therapy programs.

About

Founded in 2022, Remepy develops hybrid treatments combining pharmaceuticals with personalized digital exercises and patient progress tracking. Its app provides cognitive, psychological and behavioural activities tailored to a drug and condition. The company was founded by Dr. Michal Tsur, Or Shoval, Prof. Amir Amedi, Dr. Nira Saporta and Dr. Shahar Shelly. In August 2026, it raised USD 36 million in Series A funding co-led by M Ventures and O.G. Venture Partners, with IT-Farm Corporation, Key 1 Capital, Qumra Capital, NFX, 97212 Ventures, Fresh.fund, PsyMed Ventures, TechAviv and Vine Ventures participating.

3Funding rounds

15Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in